DE69804130T2 - Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen - Google Patents

Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen

Info

Publication number
DE69804130T2
DE69804130T2 DE69804130T DE69804130T DE69804130T2 DE 69804130 T2 DE69804130 T2 DE 69804130T2 DE 69804130 T DE69804130 T DE 69804130T DE 69804130 T DE69804130 T DE 69804130T DE 69804130 T2 DE69804130 T2 DE 69804130T2
Authority
DE
Germany
Prior art keywords
diol
alpha
mixture
skin diseases
hydroxysic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69804130T
Other languages
English (en)
Other versions
DE69804130D1 (de
Inventor
Agneta Ganemo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe BV
Original Assignee
Yamanouchi Europe BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe BV filed Critical Yamanouchi Europe BV
Publication of DE69804130D1 publication Critical patent/DE69804130D1/de
Application granted granted Critical
Publication of DE69804130T2 publication Critical patent/DE69804130T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69804130T 1997-11-25 1998-11-25 Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen Expired - Lifetime DE69804130T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25
PCT/EP1998/007759 WO1999026617A1 (en) 1997-11-25 1998-11-25 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases

Publications (2)

Publication Number Publication Date
DE69804130D1 DE69804130D1 (de) 2002-04-11
DE69804130T2 true DE69804130T2 (de) 2002-07-25

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69804130T Expired - Lifetime DE69804130T2 (de) 1997-11-25 1998-11-25 Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen

Country Status (22)

Country Link
US (1) US6399082B1 (de)
EP (1) EP1032378B1 (de)
CN (1) CN1140266C (de)
AT (1) ATE213939T1 (de)
AU (1) AU754420B2 (de)
BG (1) BG64743B1 (de)
BR (1) BR9815016A (de)
CA (1) CA2310049C (de)
CZ (1) CZ290165B6 (de)
DE (1) DE69804130T2 (de)
DK (1) DK1032378T3 (de)
ES (1) ES2174533T3 (de)
HK (1) HK1034194A1 (de)
HU (1) HU226065B1 (de)
IS (1) IS2147B (de)
NO (1) NO320100B1 (de)
NZ (1) NZ504458A (de)
PL (1) PL190023B1 (de)
PT (1) PT1032378E (de)
SK (1) SK284505B6 (de)
TR (1) TR200001486T2 (de)
WO (1) WO1999026617A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
WO1999060167A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6410036B1 (en) * 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
US8475776B2 (en) 2005-04-28 2013-07-02 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
CA2719853A1 (en) * 2008-03-25 2009-10-01 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
ES2404156T3 (es) * 2009-04-13 2013-05-24 Vanangamudi Subramaniam SULUR Una crema medicinal con ácido fusídico hecha utilizando fusidato de sodio e incorporando un biopolímero y el proceso para hacerla
AU2010244983B2 (en) * 2009-05-08 2015-07-16 Allmedic Pty Ltd Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
KR101962658B1 (ko) * 2010-11-04 2019-07-31 442 벤쳐스 엘엘씨 피부 상태를 치료하기 위한 조성물 및 방법
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
AU7656894A (en) * 1993-09-15 1995-04-03 Unilever Plc Skin care method and composition

Also Published As

Publication number Publication date
NO320100B1 (no) 2005-10-24
EP1032378A1 (de) 2000-09-06
PL190023B1 (pl) 2005-10-31
SK284505B6 (sk) 2005-05-05
HUP0100066A2 (hu) 2001-08-28
DE69804130D1 (de) 2002-04-11
PL340679A1 (en) 2001-02-12
SK7432000A3 (en) 2001-05-10
CA2310049C (en) 2008-02-19
NO20002649D0 (no) 2000-05-24
WO1999026617A1 (en) 1999-06-03
ES2174533T3 (es) 2002-11-01
HU226065B1 (hu) 2008-04-28
BG104470A (en) 2001-03-30
DK1032378T3 (da) 2002-04-15
ATE213939T1 (de) 2002-03-15
CA2310049A1 (en) 1999-06-03
NZ504458A (en) 2002-03-01
HK1034194A1 (en) 2001-10-19
EP1032378B1 (de) 2002-03-06
CN1280495A (zh) 2001-01-17
BR9815016A (pt) 2000-10-03
CZ20001920A3 (cs) 2001-04-11
TR200001486T2 (tr) 2001-07-23
PT1032378E (pt) 2002-07-31
IS5505A (is) 2000-05-23
IS2147B (is) 2006-09-15
CN1140266C (zh) 2004-03-03
CZ290165B6 (cs) 2002-06-12
HUP0100066A3 (en) 2006-07-28
US6399082B1 (en) 2002-06-04
AU754420B2 (en) 2002-11-14
NO20002649L (no) 2000-07-24
BG64743B1 (bg) 2006-02-28
AU1965999A (en) 1999-06-15

Similar Documents

Publication Publication Date Title
DE69804130T2 (de) Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
ID21761A (id) Komposisi perawatan kulit yang mengandung asam dan retinoid
DE60027016D1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
DE3587479D1 (de) Vehikel zur verabreichung von interferon.
DE59508360D1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
ATE214608T1 (de) Verwendung einer kombination bestehend aus einem aminderivat oder aminverwandten derivat der benzoesäure und einem amino-polysaccharide zur herstellung eines medikaments fuer die behandlung von entzündlichen erkrankungen
DE3689117T2 (de) Pharmazeutische Zusammensetzung mit Gehalt an einer Mischung von Kollagen und einem antiseptischen und/oder entzündungshemmenden Wirkstoff und Verfahren zu ihrer Herstellung.
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE60016770D1 (de) Verfahren zur trennung von 1,3-propandiol oder glycerin oder eine mischung davon aus einer biologischen mischung
DE69810735T2 (de) Zusammensetzung für die Behandlung von Wasser und deren Verfahren zur Herstellung
DE69429806D1 (de) Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung
DE3671365D1 (de) Topische anwendung des 3-phenylacetylamino-2,6-piperidindions zur behandlung von hautfalten und hyperpigmentierung.
DE69635298D1 (de) Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
ATE143804T1 (de) Zusammensetzung zur behandlung von mastitis und metritis
ATE157530T1 (de) Mittel zur dauerhaften haarverformung
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE69720064D1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
ATE314094T1 (de) Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche
DE69317334T2 (de) Verfahren zur Herstellung von sekundären Aminen und in diesem Verfahren zu verwendenden Katalysator
ATE53589T1 (de) Deoxyadenosinphosphat-verbindungen und verfahren zur herstellung und anwendung.
ATE55249T1 (de) Minocylin in stabiler form enthaltendes mittel zur behandlung periodontaler erkrankungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA EUROPE B.V., LEIDERDORP, NL